CAP2通过介导肿瘤细胞和肿瘤相关巨噬细胞之间的相互作用来促进胃癌转移。
CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages.
发表日期:2023 Sep 14
作者:
Guohao Zhang, Zhaoxin Gao, Xiangyu Guo, Ranran Ma, Xiaojie Wang, Pan Zhou, Chunlan Li, Zhiyuan Tang, Ruinan Zhao, Peng Gao
来源:
Cell Death & Disease
摘要:
胃癌患者(GC)的死亡主要是由癌细胞的转移所致。大量证据表明,肿瘤相关巨噬细胞在促进肿瘤浸润和转移方面起着重要作用;然而,在GC中肿瘤细胞与巨噬细胞之间的相互作用尚不清楚。在本研究中,我们证明了环化酶结合蛋白2(CAP2)在GC中上调表达,尤其在淋巴结转移的病例中,并与预后较差相关。转录因子JUN直接结合到CAP2的启动子区域并激活CAP2的转录。CAP2的N端结域与活化C激酶受体1(RACK1)的WD5-7结域结合,并通过激活SRC/ focal adhesion kinase(FAK)/ ERK信号通路诱导M2型巨噬细胞极化,进而促进白介素-4(IL4)和白介素-10(IL10)的分泌。极化的M2型巨噬细胞通过分泌转化生长因子β(TGFB1)诱导前转移信号Niche的形成并促进GC的转移,从而形成了TGFB1/JUN/CAP2正反馈环路以持续激活CAP2的表达。此外,我们发现丹酚酸B是CAP2的一种抑制剂,通过抑制SRC/FAK/ERK信号通路,有效地抑制GC细胞的侵袭能力。我们的数据表明,CAP2是介导GC细胞与肿瘤相关巨噬细胞相互作用的关键分子,可能是GC中抑制肿瘤转移的有希望的治疗靶点。
The metastasis of cancer cells is the main cause of death for patients with gastric cancer (GC). Mounting evidence has demonstrated the vital importance of tumor-associated macrophages in promoting tumor invasion and metastasis; however, the interaction between tumor cells and macrophages in GC is largely unknown. In this study, we demonstrated that cyclase-associated protein 2 (CAP2) was upregulated in GC, especially in cases with lymph node metastasis, and was correlated with a poorer prognosis. The transcription factor JUN directly bound to the promoter region of CAP2 and activated CAP2 transcription. The N-terminal domain of CAP2 bound to the WD5-7 domain of receptor for activated C kinase 1 (RACK1) and induced M2 macrophage polarization by activating the SRC/focal adhesion kinase (FAK)/ ERK signaling pathway, which resulted in interleukin-4 (IL4) and IL10 secretion. Polarized M2 macrophages induced premetastatic niche formation and promoted GC metastasis by secreting transforming growth factor beta (TGFB1), which created a TGFB1/JUN/CAP2-positive feedback loop to activate CAP2 expression continuously. Furthermore, we identified Salvianolic acid B as an inhibitor of CAP2, which effectively inhibited GC cell invasion capabilities by suppressing the SRC/FAK/ERK signaling pathway. Our data suggest that CAP2, a key molecule mediating the interaction between GC cells and tumor-associated macrophages, may be a promising therapeutic target for suppressing tumor metastasis in GC.